A metabolic enzyme studied for over seven decades has a hidden second function—it can unwind RNA and promote cell cycle progression, an additional function beyond its role in energy production, ...
Alzheimer’s disease, or AD, is a terrible illness that is currently affecting 7.2 million adults in the United States. The Alzheimer’s Association predicts that without improved medical research and t ...
EatingWell on MSN
Fiber’s big glow-up
From bland to brilliant, this once-overlooked nutrient is stepping into the spotlight—and the science says it deserves the hype.
Scientists are working hard to find better ways to treat Alzheimer’s disease, one of the most common causes of memory loss and dementia around the world. A new study from researchers at the University ...
52-week follow-up data from type 1 diabetes (“T1D”) patients in COVALENT-112 who completed ≥80% of protocol-specified dosing with the read-out expected in the second quarter of 2026. 26-week primary ...
Groundbreaking First-in-Human Study Demonstrates Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells ...
In type 1 diabetes, the immune system starts to destroy insulin-producing beta cells in the pancreas. Progressive loss of ...
No published clinical trial appears to have evaluated GlycoPezil as a proprietary formula. If you've been researching blood sugar support supplements lately, GlycoPezil is likely one of the names ...
In type 1 diabetes, the immune system starts to destroy insulin-producing beta cells in the pancreas. Progressive loss of these cells destabilizes the body's glucose levels and drives the course of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results